To read the full story, subscribe or sign in.

Deep Bio wins CE marking of AI-based prostate diagnosis software

Nov. 18, 2019

HONG KONG – South Korean biotech Deep Bio Inc. has won CE marking for its artificial intelligence (AI)-powered medical software DeepDx-Prostate Connect.

BioWorld MedTech Regulatory Cancer Diagnostics Software Digital health

Today's news in brief

BioWorld

BioWorld briefs for May 8, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for May 8, 2025.

US flag, stock market chart, White House

100 days of uncertainty

BioWorld

The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...

Illustration of cancer tumor on pancreas

PIKfyve enzyme is target to ‘starve’ pancreatic cancer cells

BioWorld

A metabolic vulnerability of pancreatic ductal adenocarcinoma (PDAC) could be used to address this type of cancer that often resists treatments. Scientists at the...

AI generated, 3D rendering of protein degradation

AACR 2025: Induced proximity strategy, beyond degraders

BioWorld

Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...